Items where Subject is "Diabetes Clinical Trials"
Group by: Creators | Item Type Number of items at this level: 26.
BBailey, S D and Xie, C and Do, R and Montpetit, A and Diaz, R and Mohan, V and Keavney, B and Yusuf, S and Gerstein, H C and Engert, J C and Anand, S S (2010) Variation at the NFATC2 Locus Increases the Risk of Thiazolidinedione-Induced Edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) Study. Diabetes Care, 33 (10). pp. 2250-3. ISSN 0149-5992 Bosch, J and Yusuf, S and Gerstein, H C and Pogue, J and Sheridan, P and Dagenais, G R and Diaz, R and Avezum, A and Lanas, F and Probstfield, J and Fodor, G and Holman, R R and Mohan, V (2006) Effect of ramipril on the incidence of diabetes. The New England journal of medicine, 355 (15). pp. 1551-62. ISSN 1533-4406 Boyko, E J and Gerstein, H C and Mohan, V and Yusuf, S and Sheridan, P and Anand, S S and Shaw, J E (2010) Effects of ethnicity on diabetes incidence and prevention: results of the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial. Diabetic Medicine, 27 (11). p. 1226. DDecoda, Study (2007) Prevalence of the metabolic syndrome in populations of Asian origin☆Comparison of the IDF definition with the NCEP definition. Diabetes Research and Clinical Practice, 76 (1). p. 57. ISSN 01688227 MMohan, V and Ravikumar, R and Poongothai, S and Amutha, A and Sowmya, S and Karkhuzali, K and Parkin, C G (2010) A single-center, open, comparative study of the effect of using self-monitoring of blood glucose to guide therapy on preclinical atherosclerotic markers in type 2 diabetic subjects. Journal of diabetes science and technology, 4 (4). pp. 942-8. ISSN 1932-2968 NNing, F and Qiao, Q and Tuomilehto, J and Hammar, N and Ho, S Y and Söderberg, S and Zimmet, P Z and Shaw, J E and Nakagami, T and Mohan, V and Ramachandran, A and Lam, T H and Andersson, S W and Janus, E D and Boyko, E J and Fujimoto, W Y and Pang, Z C (2010) Does abnormal insulin action or insulin secretion explain the increase in prevalence of impaired glucose metabolism with age in populations of different ethnicities? Diabetes/Metabolism Research and Reviews, 26 (4). pp. 245-53. ISSN 15207552 Nyamdorj, R and Pitkäniemi, J and Tuomilehto, J and Hammar, N and Stehouwer, C D A and Lam, T H and Ramachandran, A and Janus, E D and Mohan, V and Söderberg, S and Laatikainen, T and Gabriel, R and Qiao, Q (2011) Ethnic comparison of the association of undiagnosed diabetes with obesity. International Journal of Obesity, 35 (2). p. 313. ISSN 0307-0565 PPatel, A and Mohan, V (2007) Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial. The Lancet, 370 (9590). p. 829. ISSN 01406736 Patel, V and Chatterji, S and Chisholm, D and Ebrahim, S and Gopalakrishna, G and Mathers, C and Mohan, V and Prabhakaran, D and Ravindran, R D and Reddy, K S (2011) Chronic diseases and injuries in India. The Lancet . ISSN 01406736 Patel, V and Chatterji, S and Chisholm, D and Ebrahim, S and Gopalakrishna, G and Mathers, C and Mohan, V and Prabhakaran, D and Ravindran, R D and Reddy, K S (2011) Chronic diseases and injuries in India. The Lancet, 377 (9763). p. 413. ISSN 01406736 Poongothai, S and Anjana, R M and Pradeepa, R and Ganesan, A and Umapathy, N and Mohan, V (2010) Prevalence of Depression in Relation to Glucose Intolerance in Urban South Indians—The Chennai Urban Rural Epidemiology Study (CURES-76). Diabetes Technology & Therapeutics, 12 (12). p. 989. ISSN 1520-9156 Poongothai, S and Anjana, R M and Pradeepa, R and Ganesan, A and Unnikrishnan, R and Rema, M and Mohan, V (2011) Association of Depression with Complications of Type 2 Diabetes – The Chennai Urban Rural Epidemiology Study (CURES- 102). JAPI, 59 . pp. 640-4. Poongothai, S and Mohan, V (1999) Trial of Once Daily Gemfibrozil (900mg) in the treatment of Hyperlipidemia in diabetes. The Asian Journal of Diabetology, 1 . pp. 19-22. RRadha, V and Ek, J and Anuradha, S and Hansen, T and Pedersen, O and Mohan, V (2009) Identification of Novel Variants in the Hepatocyte Nuclear Factor-1 Gene in South Indian Patients with Maturity Onset Diabetes of Young. Journal of Clinical Endocrinology & Metabolism, 94 (6). p. 1959. ISSN 0021-972X Rajmohan, L and Mohan, V (1997) Drug induced Diabetes Mellitus. japi, 45 . pp. 876-9. Ramachandran, A and Mohan, V and Snehalatha, C and Chinnikrishnudu, M and Viswanathan, M (1988) Use of metformin in selected cases of NIDDM: A clinical trial. The journal of diabetic association of india, 28 . pp. 137-9. SSonya, J and Ranjani, H and Pradeepa, R and Mohan, V (2010) Obesity Reduction and Awareness and Screening of Noncommunicable Diseases through Group Education in children and adolescents (ORANGE): methodology paper (ORANGE-1). Journal of diabetes science and technology, 4 (5). pp. 1256-64. ISSN 1932-2968 Study, The DREAM Trial and Mohan, V (2011) Long-term effect of rosiglitazone and/or ramipril on the incidence of diabetes. Diabetologia, 54 (3). pp. 487-95. ISSN 0012-186X Sudhakaran, C and Anjana, R M and Rao, K and Unnikrishnan, R and Suresh, T and Mohan, V (2009) Role of Continuous Subcutaneous Insulin Infusion in Patients with Recalcitrant Diabetes in South India. Diabetes Technology & Therapeutics, 11 (11). p. 733. ISSN 1520-9156 Sudhakaran, C and Fathima, M and Anjana, R M and Ranjit Unnikrishnan, I and Mohan, V (2010) Effectiveness of Exenatide in Asian Indians in a Clinical Care Setting. Diabetes Technology & Therapeutics, 12 (8). p. 613. ISSN 1520-9156 Sudhakaran, C and Kishore, U and Anjana, R M and Unnikrishnan, R and Mohan, V (2011) Effectiveness of Sitagliptin in Asian Indian Patients with Type 2 Diabetes—An Indian Tertiary Diabetes Care Center Experience. Diabetes Technology & Therapeutics, 13 (1). p. 27. ISSN 1520-9156 Sudhakaran, C and Kishore, U and Anjana, R M and Unnikrishnan, R and Mohan, V (2011) Effectiveness of Sitagliptin in Asian Indian Patients with Type 2 Diabetes—An Indian Tertiary Diabetes Care Center Experience. Diabetes Technology & Therapeutics, 13 (1). pp. 27-32. ISSN 1520-9156 TThe ORIGIN Trial, Study (2008) Rationale, design, and baseline characteristics for a large international trial of cardiovascular disease prevention in people with dysglycemia: The ORIGIN Trial (Outcome Reduction with an Initial Glargine Intervention). American Heart Journal, 155 (1). 26.e1. ISSN 00028703 VVijayalingam, S and Parthiban, A and Shanmugasundaram, K R and Mohan, V (1996) Abnormal antioxidant status in impaired glucose tolerance and non-insulin-dependent diabetes mellitus. Diabetic medicine : a journal of the British Diabetic Association, 13 (8). pp. 715-9. ISSN 0742-3071 Viswanathan, M and Ramachandran, A and Mohan, V (1975) Low dosage comination therapy of Glybenclamide and Phenformin Maturity - onset Diabetes. Journal of Diabetic Association of Indian, 15 . pp. 145-149. ZZhang, L and Qiao, Q and Tuomilehto, J and Janus, E D and Lam, T H and Ramachandran, A and Mohan, V and Stehouwer, C D A and Dong, Y and Nakagami, T and Onat, A and Soderberg, S (2010) Distinct Ethnic Differences in Lipid Profiles across Glucose Categories. Journal of Clinical Endocrinology & Metabolism, 95 (4). pp. 1793-1801. ISSN 0021-972X |